Helsinn Group announces the launch of the IV formulation of AKYNZEO® (fosnetupitant/palonosetron) in the United States

8 May 2018

NovellusDx announces it has completed an equity financing of $6 million

3 May 2018

Cerbios-Pharma Successfully Passes a General FDA cGMP Inspection

30 April 2018

Winners of the inaugural Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced

24 April 2018

1 Taiho Pharmaceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy

24 April 2018

Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/palonosetron) in the United States

24 April 2018

Helsinn Group to Present a Poster at Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2018

24 April 2018

Cerbios-Pharma SA – Enterococcus faecium SF68®: a model for efficacy and safety for Pharmaceutical Probiotics

20 April 2018

Cerbios’ Senior Scientist on Antibody Drug Conjugates

6 April 2018

APR Applied Pharma Research – PKU Management: insights from a global market research by APR

5 April 2018